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Lubrol-RAFTs in Melanoma Cells: A Molecular
Platform for Tumor-Promoting Ephrin-B2–Integrin-b1
Interaction
Stefanie Meyer1, Evelyn Orso´2, Gerd Schmitz2, Michael Landthaler1 and Thomas Vogt1
Ephrins control cell motility and matrix adhesion. These functions play a pivotal role in cancer progression, for
example, in malignant melanomas. We have previously shown that the ephrin-B2-tumor-promoting action is
partly mediated by integrin-b1 interaction. However, the subcellular prerequisites for molecular interaction like
molecular proximity and co-compartmentalization have not been elucidated yet. Specific cholesterol-rich
microdomains, termed lipid rafts (RAFTs), are known to be essential for functional ephrin-B2 signalling and
integrin-mediated effects. Therefore, we addressed the question whether RAFT co-compartmentalization of
both molecules could provide the molecular platform for their tumor-promoting interaction. In this study, we
show that overexpressed ephrin-B2 is not only compartmentalized to classical Triton X-100 RAFTs in B16
melanoma cells, but also to the recently defined Lubrol-RAFTs. Interestingly, in the melanoma cells investigated,
integrin-b1 is also preferentially detected in such Lubrol-RAFTs. Accordingly, the presence of ephrin-B2 and
integrin-b1 in RAFTs and their function in cell migration and matrix attachment are highly sensitive to RAFT
disruption by cholesterol depletion. Confocal fluorescence microscopy analyses also support the concept of a
close molecular proximity and functional interplay of ephrin-B2 and integrin-b1 in the plasma membrane. We
conclude that Lubrol-RAFTs probably represent the platform for tumor-promoting ephrin-B2–integrin-b1
interaction, which could become an interesting target for future antitumoral therapies.
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INTRODUCTION
The plasma membrane contains specific microdomains,
termed lipid rafts (RAFTs), that may provide the necessary
proximity of molecules involved in cell signalling (Simons
and Toomre, 2000). RAFTs are characterized by their
enrichment in glycosphingolipids and cholesterol, and can
harbor unique protein compositions. In response to intra- or
extracellular stimuli, RAFTs can obviously exclude or include
proteins selectively (Palmer et al., 2002). Thus, they are
considered to be dynamic sites of signal integration, where
interacting proteins are arranged and complexed together in
close proximity to facilitate specific and efficient signal
transduction. RAFTs exhibit differential detergent sensitivity
and different subtypes of RAFTs can be defined and isolated
on this basis (Simons and Toomre, 2000).
B-ephrins are cell surface-bound ligands of Eph-B-receptor
tyrosine kinases. Intercellular interaction between ephrin and
Eph-receptor tyrosine kinase triggers bidirectional signalling
through their intercellular cytoplasmic signalling domains
that recruit a variety of motogenic downstream effectors
(Cowan and Henkemeyer, 2002). The induced signals play a
pivotal role in both guiding and patterning of normal cells
during development, for example, of the vascular network
(Adams et al., 1999; Foo et al., 2006) and probably in cancer
cell migration and survival (Meyer et al., 2005). Physiologi-
cally, the active signalling-competent fraction of B-ephrins
reside in RAFTs (Palmer et al., 2002). Integrins, which also
reside in RAFTs, are among the important effector molecules
downstream of ephrin-B (Cowan and Henkemeyer, 2001,
2002; Henkemeyer et al., 1996). We have recently shown
that ephrin-B2 enhances integrin-b1-mediated attachment
and migration abilities in both non-transformed intestinal
epithelial IEC-6 cells of rat (Hafner et al., 2005a, b) and
malignant B16 mouse melanoma (MM) cells (Meyer et al.,
2005). As this ephrin–integrin interplay may be a common
principle of cancer cell motility that ultimately contributes to
cancer progression, we addressed the question whether the
involved proteins may coexist in RAFT microdomains that in
turn provide the necessary proximity for the enhancement of
ephrin-B downstream cascades.
A better understanding of RAFTs in cancer cells is highly
desirable, as RAFT functions could become an interesting
drug-target of the future. Currently, there is already growing
evidence that some effects of several drugs applied in cancer
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therapy are in fact related to modifications of RAFT
microdomains, for example, the cytotoxic agent cisplatin in
human colon cancer (Lacour et al., 2004), the anti-CD20
therapeutic antibody rituximab in B-cell lymphoma (Semac
et al., 2003), the antitumor ether lipid ET-18-OCH(3) in
human leukemia (Gajate and Mollinedo, 2001), or the
antilipidemic agent simvastatin in prostate cancer (Zhuang
et al., 2005).
RESULTS
RAFT disruption minimizes attachment and migration of B16
MM cells overexpressing ephrin-B2
In our previous work, we have demonstrated that ephrin-
B2–integrin-b1 interplay is a key element of cell attachment
to extracellular matrix components like fibronectin and
laminin in malignant B16 mouse MM cells (Meyer et al.,
2005). As specific inhibition of those molecules with mAbs or
soluble-receptor domains minimized cell attachment and
migration on fibronectin/laminin, and both molecules de-
pend on RAFTs (Bruckner et al., 1999; Pande, 2000; Brown,
2002; Palmer et al., 2002), one would expect that RAFT
disruption is equally effective in minimizing attachment and
migration of ephrin-B2 overexpressing B16 MM cells.
Consistent with this assumption an almost complete blocking
of this B16 cell attachment could be achieved by disruption
of RAFT microdomains using non-toxic concentrations of
methyl-b-cyclodextrin (CD, 10 mM) for chemical cholesterol
depletion before cell seeding (Figure 1). This inhibitory effect
was not observed with ApoA1 (10 mg/ml), an agent that
requires the presence of specific lipoproteins for depletion.
As specific blocking of ephrin and integrin pathways with
mAbs or soluble-receptor domains also minimized the
migratory competence of ephrin-B2 overexpressing B16
MM cells (Meyer et al., 2005), we also investigated the
effects of cholesterol depletion on migratory competence. For
assessment of migratory speed, we employed Boyden
chambers and in vitro scratch wounding. Compatible with
the assumption that RAFT disruption should minimize
migratory competence, at least to a similar extent as specific
blocking of ephrin/integrin pathways, ephrin-B2 overexpres-
sing B16 MM cells showed a significant (Po0.05) decrease of
migration through Boyden filters after CD treatment (Figure
2a). The scratch-wound assays performed also document a
considerable reduction of cell motility upon CD treatment
(Figure 2b, d vs c, e). Of note, CD-treated cells show a
roundish morphology and lack lamellipodial protrusions
(Figure 2c), but still keep a residual competence of motility
(Figure 2e).
Ephrin-B2 and integrin-b1 are compartmentalized to Lubrol
WX-RAFTs in MM cells
To demonstrate that ephrin-B2 and integrin-b1 are in fact
targeted to RAFT microdomains in the cells used, RAFT
membrane fractions were prepared in sucrose gradients and
immunoblotted as described. Interestingly, all ephrin-B2-
expressing melanoma and colorectal cancer cell lines
compartmentalize ephrin-B2 in both the classical Triton
X-100 RAFTs and the recently described Lubrol WX-insoluble
RAFTs (Figure 3 and Table 1). Triton X-100-prepared RAFTs
have previously been shown to harbor ephrin-B1/2 in some
other cell lines (Manes et al., 1999; Palmer et al., 2002), but it
is a new finding that ephrin-B2 is also compartmentalized in
Lubrol-RAFTs. Integrin-b1 was even preferentially detected in
Lubrol-RAFTs of ephrin-B2-expressing MM cell lines (Figure 3
and Table 1). Therefore, one could assume that a functional
interaction between ephrin-B2 and integrin-b1 may take
place in close proximity within specific Lubrol-RAFTs. In
colorectal cancer cells, integrin-b1 was not as abundant to be
detected in the immunoblot in both Lubrol- and Triton-RAFTs
(Table 1), which does not exclude an interplay of ephrin-B2
with other members of the integrin family.
Interestingly, immunoblotting of pretreated CD cells
shows that both ephrin-B2 and, in part, integrin-b1 are
dislodged from RAFT compartmentalization (Figure 3). As
flow cytometry did not demonstrate significant changes of the
cell-surface expression levels of ephrin-B2 and integrin-b1
after CD treatment (data not shown), the observed effects are
mainly relocalization or redistribution processes of cell-
surface proteins within the cell membrane and not because of
dissolving or shedding of functional proteins by simple
detergent effects.
Together with our results concerning minimized attach-
ment and migration after CD treatment, our findings support
the concept that ephrin-B2 localization in Lubrol-RAFT
microdomains is a prerequisite for integrin-b1-mediated cell
attachment and motility competence in B16 F10 and possibly
other ephrin-B2-expressing MM cells.
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Figure 1. RAFT disruption minimizes attachment of B16 MM cells
overexpressing ephrin-B2. Ephrin-B2 overexpressing B16 cells show a
significantly increased attachment on fibronectin (FN) when compared with
mock-transfected cells. Cholesterol depletion by CD (10 mM) minimizes the
attachment indicating a possible RAFT dependence of ephrin-B2. ApoA1
(10mg/ml), an agent that requires the presence of specific lipoproteins for
depletion, did not affect the FN attachment of transfected B16 cells.
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Confocal imaging supports partial co-compartmentalization of
integrin-b1 and ephrin-B2 in the plasma membrane of B16 MM
cells overexpressing ephrin-B2
In ephrin-B2 overexpressing B16 MM cells (Figure 4e–h)
versus ‘‘mock’’ transfectants (Figure 4a–d), simultaneous
fluorescence detection of integrin-b1 and ephrin-B2 demons-
trates a dotted colocalization of both molecules along the
plasma membrane (Figure 4j). Interestingly, this is particularly
prominent in lamellipodial protrusions (Figure 4j, pointed by
arrowheads) suggesting a role of ephrin-B2–integrin-b1 inter-
play in lamellipodial crawling.
DISCUSSION
Eph-receptors and ephrins are known to play an important
role in cancer progression in a variety of organs (reviewed by
Hafner et al., 2004). We have previously shown that ephrin-
B2 is upregulated during melanoma progression (Vogt et al.,
1998) and demonstrated that ephrin-B2 promotes extracel-
lular matrix attachment and migration of B16 melanoma cells
in an integrin-b1-dependent manner (Meyer et al., 2005). The
most important finding of this study is that specific Lubrol-
RAFTs in MM cells harbor both types of molecules and
probably provide the platform for ephrin-B2–integrin-b1
interaction.
RAFT membrane microdomains have been proposed to
act as sites of signal integration providing the proximity
required for interacting signalling molecules (Simons and
Toomre, 2000). For A-ephrins, it was already demonstrated
that these proteins are glycosylphosphatidylinositol-anchored
on the extracellular layer of the plasma membrane and
accumulate in detergent-insoluble glycolipid-enriched RAFTs
in their functional state (Davy and Robbins, 2000). Notably,
some of the interacting downstream effectors of ephrin-
dependent reverse signalling cascades such as Src and Fyn
are typically associated with the inner leaflet of the same
lipid-rich domains (Cowan and Henkemeyer, 2002). A
similar meaning of RAFTs as integrating platforms to deliver
ephrin-reverse signals is also known for B-ephrins, which are
tethered to the membrane by transmembrane domains. The
transmembrane domains of active ephrin-B molecules are
also targeted to cholesterol-rich RAFT microdomains at least
in some tissues (Palmer et al., 2002). For instance, in
embryonic mouse brain cells (Palmer et al., 2002), NIH3T3
fibroblasts (Palmer et al., 2002), or MCF-7 breast adeno-
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Figure 2. RAFT disruption minimizes migration of B16 MM cells overexpressing ephrin-B2. (a) Boyden chamber migration experiments performed with
ephrin-B2 and mock-transfected B16 cells: treatment with CD also results in a significantly reduced invasive migratory competence of ephrin-B2
overexpressing cells indicating an important role of RAFT-dependent molecules. (b–e) Scratch-wound assays visualize the decelerated migration of
ephrin-B2-transfected B16 cells after CD treatment. (b and d corresponds to cells not treated with CD, 0 and 4 hours after wounding; c and e corresponds to cells
treated with CD, 0 and 4 hours after wounding). Of note, CD-treated cells show a roundish morphology and a lack of lamellipodia.
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Figure 3. Ephrin-B2 and integrin-b1 are compartmentalized to Lubrol
WX-RAFTs in MM cells. Western blot analysis of Triton X-100 and Lubrol
WX-resistant low-density fraction (1–5) and high-density membrane fractions
(6–8) from ephrin-B2 overexpressing B16 MM cells: ephrin-B2 can be found in
Triton X-100 and Lubrol –WX-prepared RAFTs. Integrin-b1 is exclusively
found in Lubrol WX-RAFTs. Actin was used as a marker of the non-RAFT
protein fraction (high-density fraction 6–8), caveolin as a typical RAFT marker
(low-density fraction 1–5) to ensure proper performance of the sucrose
gradients. CD treatment results in disruption of the RAFT composition and loss
of detectability of ephrin-B2 in the detergent-insoluble membrane fraction.
RAFT-compartmentalization of integrin-b1 is also reduced by CD treatment,
but seems to be less sensitive.
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carcinoma cells (Manes et al., 1999) ephrin-B1/2 were
detected in Triton X-100 RAFTs. In this study, we could
confirm Triton-RAFT compartmentalization of ephrin-B2 in
ephrin-B2 overexpressing B16 MM cells and some other MM
and colorectal cancer cell lines with wild-type expression of
ephrin-B2. However, in the immunoblot, considerable
amounts of ephrin-B2 were not only detected in Triton X-
100 RAFTs but also found in Lubrol WX-RAFTs, a RAFT
Table 1. Compartmentalization of ephrin-B2 and integrin-b1 in the LDFs of Triton X-100 or Lubrol WX-prepared
RAFTs in different melanoma and colorectal cancer cell lines according to immunoblot detection
Melanoma cell lines Colorectal cancer cell lines
Mouse Human Mouse Human
B16 (neg. control)1 B16 ephrin-B2 transfected HTB66 HTB70 A375SM CT26 SW620
LDF LDF LDF LDF LDF LDF
Triton
X-100
Lubrol
WX
Triton
X-100
Lubrol
WX
Triton
X-100
Lubrol
WX
Triton
X-100
Lubrol
WX
Triton
X-100
Lubrol
WX
Triton
X-100
Lubrol
WX
Triton
X-100
Lubrol
WX
ephrin-B22   + + + + + + + + + + + +
Integrin-b13  +  +  +  +  +    
LDF, low-density fractions.
1B16 melanoma cells without wild-type expression of ephrin-B2 () were used as negative control.
2Ephrin-B2 was detected (+) in both Triton X-100 and Lubrol WX-RAFTs in all ephrin-B2-expressing cell lines.
3Integrin-b1 was exclusively detected (+) in Lubrol-RAFTs in melanoma cell lines.
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Figure 4. Integrin-b1 is partly co-compartmentalized with ephrin-B2 in the plasma membrane of B16 MM cells overexpressing ephrin-B2. Representative
confocal images of (a–d) ‘‘mock’’ transfectants versus (e–h) ephrin-B2-transfected B16 cells. The distribution of ephrin-B2 (red) or integrin-b1 (green) was
evaluated by immunofluorescence. Nuclei were counterstained with 4,6-diamidino-2-phenylindole (blue). Overlaps representing colocalization of ephrin-B2
and integrin-b1 are merged as yellow. This is most evident in lamellipodial protrusions of the plasma membrane. ((j) arrowheads: detail of merged image (i);
bar¼ 0.03 mm (i); bar¼0.01 mm (j)).
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microdomain entity recently characterized by Roper et al.
(2000). Lubrol-RAFT compartmentalization of ephrin-B2 has
not been reported previously. Integrin-b1, one important
partner molecule for ephrin-B2 mediating increased attach-
ment and migration competence of MM cells (Meyer et al.,
2005), even showed a preference for Lubrol-RAFTs in all MM
cell lines analyzed. In contrast, in colorectal cancer cells,
integrin-b1 was not detectable in the low-density immuno-
blot fractions. This does not exclude that other integrins might
interact with ephrin-B2 in Lubrol-RAFTs of colorectal cancer
cells. Analyses of progression competent colorectal cancer
cells suggest a more prominent role of avb6 (Bates, 2005) in
this system. It would be interesting to study possible targeting
of integrin avb6 to Lubrol-RAFTs in colorectal cancer cells.
So far, very little is known about the meaning of RAFT
composition and trafficking in MM cells. Iwabuchi et al.
(1998) reported on the separation of ‘‘glycosphingo-
lipid signalling domain’’ from caveolin-containing membrane
fraction in MM B16 cells and its role in cell adhesion
coupled with signalling. Accordingly, they showed that
certain gangliosides, for example, GM3, which enhance
the specific binding to endothelial cells, reside in Triton
X-100 RAFTs of B16 MM cells. The same RAFTs also
contain signal-mediating proteins such as c-Src, Rho A, Ras,
and focal adhesion kinase-signalling proteins. The compart-
mentalization of ephrin-B2 and integrin-b1 in Lubrol
WX-RAFTs, as detected in our study, is a novel aspect in
MM cell lines.
Lubrol-RAFTs, which reveal a higher total content of
sphingomyelin and phosphatidylcholine as well as a different
lipid species composition, most prominent a higher content
of unsaturated phosphatidylcholine species compared with
Triton-RAFTs (Drobnik et al., 2002), seem to be particularly
relevant for targeting proteins to specialized cell protrusions
such as the microvilli in epithelial cells (Roper et al., 2000)
and the filopodia in macrophages (Drobnik et al., 2002). The
function of both ephrins and integrins is assumed to be
critically regulated by clustering and trafficking of RAFT
microdomains, access to RAFTs, and exclusion from RAFTs
(Davy et al., 1999; Pande, 2000; Palmer et al., 2002).
Specifically, it was shown that upon stimulation of cell
migration, ephrin-B molecules are asymmetrically redistribu-
ted to the leading edge of migrating cancer cells, where it
locates in large coalescing plaques of RAFT microdomains
(Manes et al., 1999). Likewise, integrins that build up the
traction forces at the leading edge of a cell depend on RAFT
mobility (Pande, 2000; Holleran et al., 2003). Consequently,
chemical disruption of RAFTs by cholesterol-depleting agents
paralyses the involved systems almost completely. Accord-
ingly, in the attachment and migration assays performed with
the ephrin-B2-transfected B16 MM cells, cholesterol deple-
tion by CD treatment diminished attachment and migration to
an extent comparable with specific blocking of ephrin and
integrin pathways observed in previous studies (Meyer et al.,
2005). Although CD exerts a nonspecific effect on all RAFT-
residing proteins, purging of ephrin-B2 and integrin-b1 from
RAFT compartments as demonstrated by immunoblotting
(Figure 3) could be a key element of undermining attachment
and migration competence of MM cells and possibly other
cancer cells.
Our fluorescence image data also support the concept that
a direct interplay between ephrin-B2 and integrin-b1 might
exist particularly within lamellipodial membranes of actively
attaching or migrating cells. Active lamellipodial movement
requires a principle that allows a highly adaptable trafficking
and lateral movement of the involved molecules within the
moving plasma membrane protrusions. Our data give rise to
the theory that Lubrol-RAFTs could be the corresponding
platform and necessary vehicle for ephrin-B2 and integrin-b1.
Selective routing of ephrin-B2 into Lubrol-RAFTs could lead
to an accumulation within cell protrusions (e.g., anterior
lamellipodia) probably in close association with effector
molecules such as members of the integrin family that
provides adaptive connections to matrix components and to
points of tethering to pull forward. However, we do not have
direct evidence that confocal signals are congruent with
clusters of Lubrol-RAFTs owing to the current lack of Lubrol-
RAFT-specific staining techniques.
As more and more antitumoral drugs (Gajate and
Mollinedo, 2001; Semac et al., 2003; Lacour et al., 2004;
Menendez et al., 2005; Zhuang et al., 2005) for RAFT-
targeting evolve, further analyses of the specifics of RAFT
composition and trafficking during transformation of mela-
nocytic cells with special attention to cell motility-related
molecules are necessary to open new horizons for the
development of novel therapies for MM.
MATERIALS AND METHODS
The medical ethical committee of the University of Regensburg,
Germany, approved all described experiments. The study was
conducted according to the Declaration of Helsinki Principles.
Cell lines
RAFT compartmentalization of ephrin-B2 and integrin-b1 was
analyzed in cancer cell lines with high constitutive expression of
ephrin-B2 (Meyer et al., 2005): the human melanoma (MM) cell lines
HTB66, HTB70, A375SM and for comparison with non-melanoma
cells, the colorectal cancer cell lines SW620 (human) and CT26
(mouse). Wild-type B16 F10 (mouse MM) cells served as ephrin-B2-
negative control. B16 F10 MM cells were also used as a model for
stable transfection and overexpression of mouse full-length ephrin-
B2 as described previously (Meyer et al., 2005).
Cholesterol depletion
In order to demonstrate the influence of intact RAFTs on motility
functions of B16 F10 MM cells, we employed standard techniques
for cholesterol depletion and disruption of RAFTs by applying either
CD, a cyclic oligosaccharide that chemically extracts cholesterol
from the membranes, or specific cholesterol depletion by ApoA1
(Roper et al., 2000). In the corresponding experiments, cells were
mechanically detached and washed twice with medium containing
1% bovine serum albumin. Subsequently, the cells were incubated
with 10 mM CD in serum-free medium containing 50 mM (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid) (30 minutes at 371C)
before proceeding to the individual protocols for testing of cell
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attachment and motility. Under these conditions, CD treatment does
not affect cell viability (data not shown).
Attachment assays
Twenty-four-well plates (Falcon, Bedford, MA) were incubated
overnight at 41C with phosphate-buffered saline containing defined
concentrations of rodent fibronectin (5mg/ml). All cells used were
serum-starved for 24 hours in fetal calf serum-free RPMI 1640.
Attachment assays were performed as described previously (Meyer
et al., 2005), with and without CD- or ApoA1 pretreatment, and all
individual experiments were replicated in four wells.
Boyden chamber analysis and scratch-wound assays
The Chemicon QCMTM-fibronectin quantitative cell migration kit
(Chemicon, Temecula, CA) was used for assaying the migratory
competence in Boyden chamber analysis as described (Meyer et al.,
2005). All individual experiments were performed in quadruplicate,
with and without CD pretreatment.
For better visualization of the migration competence, in vitro
monolayer scratch-wound assays were performed as well (Meyer
et al., 2005). Digital images of wound closure were taken 0 and
4 hours after wounding. Assessment of wound closure and statistical
analysis were performed as described previously (Meyer et al.,
2005).
Sucrose flotation gradients and immunoblotting
Cells were scraped in phosphate-buffered saline containing 0.02%
sodium azide and subsequently centrifuged for 5 minutes at
900 r.p.m. The cell pellets (3.0–7.0 mg of protein) were then lysed
for 30 minutes on ice in 800 ml ice-cold lysis buffers containing
50 mM Tris, 150 mM NaCl, 5 mM EDTA, 200mM aminoethylbenzene-
sulfonylfluoride, 160mM aprotinin, 10 mM bestatin, 3 mM E64-protease
inhibitor, 4 mM leupeptin, 2mM pepstatin A (TNE buffer; all protease
inhibitors from Calbiochem, Bad Soden, Germany) and either 1%
Triton X-100 (Boehringer, Mannheim, Germany) or 1% Lubrol WX
(Serva, Heidelberg, Germany) as detergent. The lysates were brought
to 1.2 M sucrose by adding 400ml of 2.4 M sucrose in TNE-buffer
placed on the bottom of a SW55 TI tube (Beckman/Coulter/
Immunotech, Fullerton, CA) and underlaid with 1.2 ml of 0.1 M,
1.2 ml of 0.7 M, 0.6 ml of 0.8 M, and 1.2 ml of 0.9 M sucrose in TNE-
buffer. Samples were ultracentrifuged at 303,800 g at 41C for
16 hours. After centrifugation, 600-ml fractions were collected from
the top to the bottom. Fractions 1–5 represent the low-density
fraction and fractions 6–8 the high-density fraction. All fractions and
the remaining pellet (resuspended in 0.2% SDS-TNE) were subjected
to methanol/chloroform precipitation, and equal amounts from each
fraction were analyzed by SDS-PAGE using 12% gels. After
electrophoresis, proteins were transferred to Hybond enhanced
chemoluminescence nitrocellulose membranes (Amersham, Life
Science, Freiburg, Germany). For detection of ephrin-B2/integrin-
b1, membranes were incubated over night at 41C with a polyclonal
anti-ephrin-B2 antibody (R&D-Systems, Wiesbaden, Germany)/
monoclonal anti-integrin-b1-antibody (clone 18, BD Biosciences,
Heidelberg, Germany) in a dilution of 1:500/1:2,000. Anti-actin
antibody (clone AC-40, monoclonal mouse, Sigma, St Louis, MO)
was used as a marker for the non-RAFT protein fraction, anti-a
caveolin 1 (N-20, polyclonal rabbit, Santa Cruz Biotechnology,
Santa Cruz, CA) as a typical RAFT marker. Anti-actin antibody/anti-
caveolin antibody was incubated over night at 41C in a dilution of
1:500/1:1,000. Antibody-positive bands were visualized by incuba-
tion with appropriate horseradish peroxidase-labelled secondary
antibodies. The membranes were subjected to enhanced chemo-
luminescence Western blotting detection reagent (Amersham/Pharma-
cia, Freiburg, Germany), exposed to Hyperfilm enhanced chemolu-
minescence high-performance chemiluminescence films (Amer-
sham/Pharmacia, Freiburg, Germany) for 1 min/10 minutes and
developed by using a Kodak M35 X-Omat processor.
Confocal microscopy
Immunfluorescence of transfected cells was carried out according to
standard procedures. In brief, cells cultured on Lab-TekTM sodium
borosilicate coverslips (Nunc, Wiesbaden, Germany) were fixed
with methanol:acetone (1:1) at 201C and permeabilized with 0.2%
Triton X-100 (Calbiochem, Bad Soden, Germany). Nonspecific
binding sites were blocked with 2% bovine serum albumin (Sigma,
Deisenhofen, Germany) in Tris-buffered saline (pH: 7.3) containing
1% non-fat dried milk. The cells were incubated with biotinylated,
affinity-purified goat IgG against recombinant mouse ephrin-B2
(1:200, R&D Systems, Wiesbaden, Germany) and FITC-conjugated
monoclonal rat anti-mouse integrin-b1 (1:500, clone 9GE7, Phar-
mingen/BD Biosciences, Heidelberg, Germany) for 1 hour at room
temperature. After extensive washing, samples were incubated with
Cy5-conjugated streptavidin (1:500, Jackson ImmunoResearch,
Soham, Cambridgeshire, UK) for 30 minutes at room temperature.
Nuclei were counterstained with 4,6-diamidino-2-phenylindole
(Molecular Probes, Leiden, The Netherlands) directly before micro-
scopic examination. Fluorescence images were analyzed by using a
TCS SP2 AOBS inverse confocal scanning microscope (Leica,
Wetzlar, Germany), equipped with a UV laser-diode, a multiline
argon laser as well as a green and a red He/Ne laser. The system is
equipped with three detection channels, and the wavelengths of the
excitation are 405, 488, and 633 nm, respectively. High resolution
images were taken in three channels sequentially, blue channel for
4,6-diamidino-2-phenylindole, green channel for FITC, and the red
channel for Cy5. Merged images (yellow) showing colocalization
were generated after separate data analysis on each channel.
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